<DOC>
	<DOCNO>NCT02725242</DOCNO>
	<brief_summary>This study evaluate efficacy Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg period step well control asthmatic patient .</brief_summary>
	<brief_title>Efficacy Once-daily Formoterol/Budesonide Turbuhaler 4.5/160 µg Step Down Asthma</brief_title>
	<detailed_description>The study measure efficacy daily low dose ICS/ LABA well control asthmatic patient compare low dose ICS step circumstance .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Asthmatic patient well control asthma least 12 week use formoterol/budesonide ( 4.5/160 ) twice daily Age 18 yearold Patients able spirometry without contraindication History smoking le 10 packyears History use systemic steroid previous 4 week respiratory infection History pulmonary tuberculosis residual lung lesion chest radiograph recent serious medical condition myocardial infarction , stroke , pneumonia etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>